The Phase 1 clinical trial is expected to enroll about 60 participants to test how safe and well tolerated multiple doses of ...

Motor neuron diseases are a group of progressive and ultimately fatal neurodegenerative disorders of the motor system, ...

ATH-1105 is an orally delivered, positive modulator of the neurotrophic HGF system that is currently in a Phase 1 clinical ...

Published today in Frontiers in Neuroscience, the study fundamentally alters brain and nervous system medicine-giving doctors new clues as to why patients with motor neuron disease, multiple sclerosis ...

This is called atrophy. ALS is a progressive disease ... The most common ones are: Amyotrophic lateral sclerosis and multiple sclerosis both affect the nervous system. They have many symptoms ...

In immunotherapy trials, MRI volume loss does not correlate with degeneration. It does correlate with removal ... Anti-inflammatory treatments for multiple sclerosis initially shrink the brain, too, ...

Recent innovations, successful trials, and increased research and development spending in the healthcare sector further boost ...

Amyotrophic lateral sclerosis (ALS) is a progressive and fatal motor neuron degenerative disease characterised by ... cell death and modulation of stress granule formation across multiple stress ...

The Society for Neuroscience (SfN) will honor seven researchers who have made significant contributions to the advancement of women in neuroscience. The awards will be presented during Neuroscience ...